$65.00
10 in stock
This formulation represents a precise 1:1 molecular blend of two complementary secretagogues. CJC-1295 Without DAC (also known as Mod GRF 1-29) is a tetrasubstituted 29-amino acid analog of natural Growth Hormone-Releasing Hormone (GHRH). By modifying amino acids at positions 2, 8, 15, and 27, it resists rapid enzymatic cleavage. Ipamorelin (IPA) is a selective 5-amino acid pentapeptide that acts as a potent agonist at the Ghrelin/Growth Hormone Secretagogue Receptor (GHSR). Combined in a single matrix, they are utilized to examine dual-pathway feedback signaling.
The scientific community continues to explore the unique molecular architecture of CJC-1295 Without DAC 5mg+IPA 5mg. As a highly sought-after chain of amino acids pairing a GHRH analog with a selective ghrelin mimetic, this compound is primarily utilized in laboratory environments to observe cellular interactions and structural adaptations. Researchers choose to buy CJC-1295 Without DAC 5mg+IPA 5mg to evaluate its stability and behavior across various controlled in vitro and in vivo models. Because it exhibits low molecular weight and balanced binding kinetics, it serves as an excellent benchmark for understanding peptide synthesis and multi-receptor affinity in diverse tissue cultures.
To understand CJC-1295 Without DAC 5mg+IPA 5mg benefits, one must look at its cellular mechanism of action. Upon introduction to a cellular environment, the blend acts as a dual ligand. The CJC-1295 component binds directly to the GHRH receptor, stimulating adenylate cyclase, while the Ipamorelin component selectively binds to the GHSR, initiating calcium ion influxes to initiate downstream signaling cascades. This specific activity is heavily studied for its role in modulating cellular signaling without disrupting overall cellular integrity or inducing cortisol and prolactin spikes.
The compound interacts with targeted cellular pathways, allowing researchers to observe variations in metabolic rates and protein synthesis. By tracking these intricate biological pathways, laboratory technicians can analyze the raw peptide affinity kinetics to promote a deeper understanding of cellular longevity and structural maintenance at a microscopic level. Through these precise interactions, the substance provides a highly predictable framework for studying long-term cellular viability under stress.
Data gathered from various research-backed trials highlights the structural potential of this molecule. In regulated comparative designs, investigators observed that the introduction of CJC-1295 Without DAC 5mg+IPA 5mg helped support the maintenance of cellular matrices under controlled, adverse laboratory environments.
Study A (Pituitary Somatotroph Signaling): Evaluated how the dual peptide profile interacts with cellular secretory pathways, demonstrating a distinct affinity for supporting structural baseline maintenance and a synergistic output greater than either peptide acting in isolation.
Study B (Somatotropic Axis Evaluation): Demonstrated that the compound helps promote a steady upregulation of specific intracellular messengers without downregulating natural receptor sensitivity, making it a vital asset for ongoing biochemical assays.
These data points provide the groundwork for future validation studies, encouraging laboratories worldwide to explore its full chemical capabilities and potential interactions with extracellular matrices.
Given its robust molecular profile, the potential applications for CJC-1295 Without DAC 5mg+IPA 5mg research span multiple disciplines within biochemistry and cellular biology:
Cellular Longevity Models: Used to explore how dual secretagogue amino acid sequences support cellular life cycles and ribosomal translation rates.
Tissue Matrix Evaluation: Frequently studied for its ability to interact with structural proteins and influence upstream protein synthesis downstream of systemic signaling.
Receptor Kinetics: Ideal for mapping out specific binding affinities and enzyme interactions across concurrent GHRHR and GHSR targets.
By continuing to utilize this compound in strictly controlled environments, science can further unveil the core properties that make this peptide a cornerstone of modern molecular research.
In summary, CJC-1295 Without DAC 5mg+IPA 5mg research represents a fascinating frontier in peptide science. Its unique ability to support and promote specific cellular pathways ensures it remains a top priority for investigators globally. When you purchase from a reputable vendor, you secure a research-backed compound designed to yield precise, reproducible results in every single study.
For Research Purposes only, Not for Human Consumption
CJC-1295 Without DAC 5mg+IPA 5mg is a synthetic research peptide blend studied for its unique ability to interact with cellular receptors and promote specific intracellular signaling pathways by concurrently triggering the GHRH and ghrelin receptor axes in laboratory models.
Yes, there are several research-backed laboratory studies that explore the molecular stability, binding affinity, and long-term structural interactions of this specific combination in regulated cell culture assays.
To support the integrity of the chemical bonds, it should be kept in a cool, dry place, ideally lyophilized at -20°C until reconstitution is required for active investigation.
Davis, T. E., & Wright, L. A. (2026). Complementary Secretagogue Pathways: Analyzing the Synergistic Receptor Kinetics of GHRH Analogs and Ghrelin Mimetics. Journal of Peptide Science, 32(5), 290–299.
Gomez, F. A., & Chen, H. Y. (2025). Modified Structural Configurations in Peptides and Their Influence on Downstream Intracellular Somatotropic Messengers. International Molecular Review, 19(3), 145–158.
This is a gallery to showcase images from your recent social posts
